Agiliti Inc (AGTI)
10.10
+0.06
(+0.60%)
USD |
NYSE |
Apr 24, 16:00
10.11
+0.01
(+0.10%)
Pre-Market: 20:00
Agiliti Cash from Investing (TTM): -83.89M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -83.89M |
| September 30, 2023 | -146.48M |
| June 30, 2023 | -149.00M |
| March 31, 2023 | -150.11M |
| December 31, 2022 | -146.86M |
| September 30, 2022 | -310.97M |
| June 30, 2022 | -296.03M |
| Date | Value |
|---|---|
| March 31, 2022 | -291.18M |
| December 31, 2021 | -734.13M |
| September 30, 2021 | -507.37M |
| June 30, 2021 | -513.04M |
| March 31, 2021 | -508.12M |
| December 31, 2020 | -151.73M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-734.13M
Minimum
Dec 2021
-83.89M
Maximum
Dec 2023
-306.84M
Average
-291.18M
Median
Mar 2022
Cash from Investing (TTM) Benchmarks
| American Shared Hospital Services | -6.273M |
| Novo Integrated Sciences Inc | -- |
| Astrana Health Inc | -65.52M |
| Cryo-Cell International Inc | -7.284M |
| P3 Health Partners Inc | -1.827M |